E Kumar Sharma

Articles By E Kumar Sharma

113 Articles

In the shadow of delta: Why getting the samples early & right for sequencing matter the most

India has a set system in place to conduct surveillance and sequencing to help track the covid-19 virus mutations.

covid 19 sampling

Indian pharma upbeat as USFDA panel backs Covid-19 pill; focus now on Indian regulator

It typically needs to be administered at an early stage during the onset of the virus and today almost a dozen Indian pharma companies are ready with the product that has been developed by Merck Sharpe Dohme (or MSD) and Ridg

covid 19 pill

Meeting the IMF, RBI forecast of 9.5% GDP growth this year now a challenge, says Dr Rangarajan

Dr Rangarajan feels that perhaps we may end the year with GDP growth in the region of 7 or 8 per cent.

Expect Q2 GDP to show bounce back but concern really on sustaining it as challenges abound

Numbers still play a crucial role in judging the performance of an economy and while we are well into the third quarter of the current financial year, we have only the first quarter GDP numbers – between April and June –

New virus variant a wake-up call; test, track & trace strategies key till more data helps: Experts

Dr Swaminathan, said, typically it would take three to four weeks for the initial sets of data to start coming in from the laboratory studies.

The focus at the moment, she emphasized, needed to be on testing, tracking and tracing, especially those entering the country.

Farm laws repeal: Progress made as stalemate ends & focus shifts to agri panel, says ITC’s Sivakumar

Since the farm laws were not implemented and were already kept on hold and now repealed does not materially change matters on the ground other than signal an end to a stalemate.

However, he does believe that the outcomes set out in the preambles of the three farm laws are still required.

Farm laws repeal hailed but seen as no solution to the ills that have dogged the agri sector

Sukhpal Singh, professor and former chairperson, Centre for Management in Agriculture at the Indian Institute of Management (IIM), Ahmedabad underlined the point that the problems of the agriculture sector cannot be resolved

Indian pharma’s pitch to spur innovation, policy correctives, changes on the anvil, assures govt

Healthcare is today occupying the mindspace of most policy makers and apparently all seem keen to convey an alignment of purpose and a willingness to change and accommodate.

india pharma

Indian innovation at work: Bugworks embarks on phase I trials in its pursuit for a new antibiotic

The phase 1 clinical trial are being conducted in Adelaide, Australia.

International Science Week: Hyderabad’s C R Rao Institute dishing out cutting edge work in digital data security

The need for data confidentiality and data integrity is central for without this protective cover, all credit card details, bank transfers and communication across the internet stays unprotected and therefore exposed to the r

C R Rao Institute

What to expect as India sets in motion drug regulatory changes

Financial Express Online now learns that the recommendations have been accepted by the health ministry and it is in the process of implementing these changes and wherever approvals from the cabinet are required, the health mi

What to expect as India sets in motion drug regulatory changes

From backing the “missing middle” to meeting the health expenses of every Indian

The Niti Aayog report explains that the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) launched in September 2018, and state government extension schemes, provide comprehensive hospitalization cover to the bo


Dr Lal gets Suburban into its fold, says acquisitions crucial for growth in diagnostics

Dr Lal concluded the year ending March 31, 2021 with revenues of Rs 1581 crore, which by its size and history also conveys the time it takes to scale up in the diagnostics market.

Dr Lal gets Suburban into its fold, says acquisitions crucial for growth in diagnostics

The 10 unicorns from India that add heft in its global race

A recent report by PwC India talks of India added 10 unicorns in the third quarter of calendar year 2021.

unicorns in india

Testing Time: Indian Pharma’s foray into diagnostics

After companies like Mankind, where the promoters have funded a foray into this space, Reliance Life Sciences, a major player that offers certain niche diagnostic services and is perhaps looking at others areas too, the lates

covid 19 testing

Experts hail Covaxin approval for 2-18 year olds, favour use on children with comorbidities first

Covaxin is an inactivated vaccine while the vaccine from Biological E is a sub-unit protein vaccine. It is still under trials and is for those who are 5 years of age and more.

This recommendation is being examined and additional information has been requested at the level of Central Drugs Standard Control Organisation (CDSCO)," Pawar said.

What is an emotion worth & how can Tatas rebuild Air India?

The task on hand now is turning around this entity and it’s other challenges

Air India

What is holding back India-made medical devices?

From a bulb in an operation theatre to a high-end biochemistry analyzer (used in tests for cholesterol, blood sugar for example) by a pathological laboratory, the dependence is largely on imported devices.

medical devices

Need for real-time data is driving Indian pharma to digitise supply chains

If digitising the supply chain has become most critical, the ask is really to put in place an end-to-end solution that can help bring in operational efficiency, improve business forecasting, inventory management apart from be

digital healthcare

How committed are you for a journey to wellness?

That it is possible is shown by people who have had the discipline and the commitment to achieve tangible outcomes in their health parameters – be it getting the blood pressure or sugar levels under control backed by mind t

The blood pressure goes down while sleeping, giving the much needed rest to heart and blood vessels”;

India may soon be flooded with COVID-19 pill

The five companies are collaborating for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting in India.


Indian pharma market sees non-COVID drug sales recover

The past 18 months that forced people into social isolation and to home food and home remedies saw fewer people complaining of cold, cough and gastro-intestinal problems.


Apollo Hospitals launches heart disease risk prediction tool; doctors await peer review details

The tool has also been validated using data from the Maastricht Study, a long-term cohort health study in the Maastricht region and from the Heart+Vascular Center at Maastricht University Medical Center, Netherlands.

heart diesease

Dr Gagandeep Kang on the road ahead with COVID-19, booster shots & on inoculating approach for children

Today, after being the first to deal with the highly transmissible Delta variant and to have taken a big hit, India is now, she feels, is on a right trajectory especially with vaccinations picking up.

Gagandeep Kang

Can Health ID card be that first step in an arduous journey to digitize health records?

The study of data is what Dr Swaminathan also points as a crucial outcome of system that rides on digital health records.

digital health, Health ID card, PM Modi, Ayushman Bharat Digital Mission

Snarled supply chains hurt Indian pharma copying with spurt in Chinese raw material prices

Many in the pharma industry are today reminded of the days when the pandemic began unfolding early last year.

“Generally, we used to issue 350 to 450 new licences before the pandemic,” Dr Hemant Koshia, Gujarat FDCA commissioner, said.

PM Modi launches digital health mission. Long road ahead but here is what to expect now

It is not as if you could walk into a hospital tomorrow and expect patient health records to be made available digitally and made portable but it apparently is a first step in that direction and much depends on how the variou

narendra modi
Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market